View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Kristof Samoy
  • Kristof Samoy

CMB.Tech Signing charter agreement with Fortescue for NH3 fitted Newca...

CMB.Tech signed an agreement with the Australian miner Fortescue to charter a new ammonia-powered vessel. The 210k dwt ammonia-powered Newcastlemax will feature a dual fuel engine and is expected to be delivered by the end of 2026. No contract details have been disclosed, but as the Newcastlemax has been bought at risk by CMB a while ago the charter terms are expected to yield appealing IRRs and bring long contract duration. Following the LT charter agreement with MOL announced a few weeks back,...

Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Lewi
 PRESS RELEASE

Fortescue and CMB.TECH sign agreement for ammonia-powered ore carrier

Fortescue and CMB.TECH sign agreement for ammonia-powered ore carrier Antwerp, April 14, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMB.TECH” or the “Company”) has signed an agreement with Fortescue to charter a new ammonia-powered vessel.  This emphasises the commitment of both companies to decarbonise the shipping industry. This 210,000-dwt ammonia-powered Newcastlemax will feature a dual fuel engine and is expected to be delivered by the end of 2026. Fortescue and Bocimar, part of CMB.TECH, have signed an agreement for an ammonia-powered Newcastlemax featur...

Rune Majlund Dahl
  • Rune Majlund Dahl

Novo Nordisk (Buy, TP: DKK900.00) - Subdued prescription growth in Q1

We have updated our model with the latest IQVIA data, and see downside risk to Visible Alpha consensus. We see Q1e global sales for Wegovy of DKK17,898m (c2.2% below consensus) and Ozempic of DKK31,642m (c1.5% below consensus). While a reaffirmation of guidance could offer relief, we have lowered our target price, primarily on lower-than-expected GLP-1 sales. We reiterate our BUY but have cut our target price to DKK900 (1,040).

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

US Tariffs Navigating the impact on Benelux equities

Trumps reciprocal tariffs caused a massive blow to equity markets, following a pressured period of escalating trade wars. Retaliatory measures can further heavily damage market confidence, as seen Friday when China announced their 34% tarrif of US goods. International trade policies have never moved this erratic and untransparant, with uncertainty and volatility being the baseline for now. In this report we highlight the key stocks in our coverage relevant to this discussion.

Hilde Van Boxstael ... (+5)
  • Hilde Van Boxstael
  • Kristof Samoy
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi
 PRESS RELEASE

CMB.TECH announces final year results

CMB.TECH announces final year results CMB.TECH ANNOUNCES FINAL YEAR RESULTS TRANSFORMATIONAL YEAR AND STRONG EARNINGS ANTWERP, Belgium, 27 March 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT) reported its final financial results today for the full year ended 31 December 2024. HIGHLIGHTS 2024 Profit of USD 93.1 million in Q4 2024 bringing full year profit to USD 870.8 million​ Total contract backlog increased to USD 2.94 billionName change from Euronav to CMB.TECH (ticker symbol CMBT)CMB.TECH focused on its fleet rejuvenation with 21 newbuild delive...

Kristof Samoy
  • Kristof Samoy

CMB.Tech Landmark LT charter agreement with MOL & controlling half of ...

Last Friday Golden Ocean announced that CMB.Tech now controls two out of four of its board seats. This follows the strategic acquisition in early March of the 40.8% stake previously held by John Frederiksen. This morning during trading hours, CMB.Tech further bolstered its position by announcing a significant long-term time charter agreement with the Japanese shipping conglomerate MOL, involving nine ammonia-ready/fitted vessels. This agreement adds approximately $675 million (pro rata) to its $...

Hilde Van Boxstael ... (+4)
  • Hilde Van Boxstael
  • Kristof Samoy
  • Sharad Kumar S.P
  • Thomas Couvreur
Jørgen Lian
  • Jørgen Lian

CMB.TECH (Sell, TP: USD7.60) - Dry bulk expansion at a premium

We expect more news to be announced on its Golden Ocean ambitions in the weeks ahead, but the recent SEC filing could indicate a potential future share-based tie-up. In such a scenario, CMB.TECH would vastly expand its dry bulk exposure, with potentially cash-generating assets on the water. However, this is at odds with our more muted dry bulk sector outlook and what we believe was a premium valuation. We reinstate our recommendation with a SELL and USD7.6 target price.

Rune Majlund Dahl
  • Rune Majlund Dahl

Zealand Pharma (Buy, TP: DKK1150.00) - Deal delivery

We are positive on the partnership with Roche for petrelintide and view the financial terms as favourable for Zealand Pharma. While we had included Roche as the partner for petrelintide in our base case, the deal terms are better than we assumed. Thus, we have updated our valuation for petrelintide to DKK731 NPV/share. We reiterate our BUY and have increased our target price to DKK1,150 (1,010), based on our SOTP NPV.

Jørgen Lian
  • Jørgen Lian

‘The times they are a-changin’

The recurring theme at our 18th Energy & Shipping Conference was geopolitical uncertainty and a potential trade war, warranting a wait-and-see approach, particularly on the Trump 2.0 effect. The consensus view pointed to high asset values, with no rush to the yards, aligning with below-NAV valuations across most of our coverage. However, panellists generally saw less downside risk than the 25% average discount to steel for our Tanker, Dry Bulk and Gas coverage. Overall, the day highlighted uncer...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Air France-KLM: Surprising 4Q to the upside. CMB.TECH: A golden step into Golden Ocean? EVS: Evertz 3Q25 results. GBL: Boosting its liquidity profile. Gimv: Continued transaction spree post capital increase. Solvay: 4Q24 beat, 2025F guide in-line, reaffirmed 2028F target. Talabat: Completes InstaShop acquisition

Jørgen Lian
  • Jørgen Lian

CMB.TECH (No_rec, TP: USD) - Recommendation and target price withdrawn

The company has agreed to acquire Hemen’s Golden Ocean stake (40.8%) at a price around the peak share price in May 2024, and above the market (46%) and our NAV (15%). On the face of it, we see NAV dilution for CMB.TECH, while initially the only change for Golden Ocean shareholders is a shift in main shareholder from John Fredriksen to the Saverys family. Given DNB Markets’ role in the transaction, we have withdrawn our recommendation and target price.

Kristof Samoy
  • Kristof Samoy

CMB.Tech Acquiring 40.8% stake in Golden Ocean

CMB.Tech acquired 40.8% of Golden Ocean, the leading dry bulk shipping platform for $1.2bn in cash financed by a 21 month bridge loan. We applaud the further diversification in CMB's high conviction large vessel dry bulk segment. Buy rating reiterated.

Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Lynn Hautekeete
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi
Jørgen Lian
  • Jørgen Lian

CMB.TECH (Hold, TP: USD10.00) - Costly road to sustainable goals

CMB.TECH is transitioning into a modern, future-proof fleet and diversifying cash flows along the way. However, we believe the shift will continue to strain the company’s balance sheet and dividend potential in the coming quarters. Further, given our more constructive view on the tanker segments versus dry bulk, we continue to prefer its pure tanker peers in the near term. Hence, we reiterate our HOLD and have lowered our target price to USD10.0 (10.7).

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aalberts: Dividend and outlook better than expected. Ackermans & van Haaren: Anticipating an all-time-high result from core segments. Ageas: FY24 in line, strong capital, outlook for upsteams. AMG: Strong 4Q24 beat and 2025F guidance upgrade. CFE: Solid results and balance sheet, outlook weak. CMB.TECH: Cautious on outlook. Corbion: Not so sweet. CTP: Good results, 2025 outlook realistic. D'Ieteren: Boyd's Five-Year Goals. Exor: Ferrari €3bn ABB and €1bn SBB. Sofina: Further ...

Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Kristof Samoy
  • Michiel Declercq
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Morning Notes : AALB NA, AGS BB, ARGX BB, CFEB BB, CRBN NA, CMBT BB, M...

: AALB NA, AGS BB, ARGX BB, CFEB BB, CRBN NA, CMBT BB, MDXH BB, PNL NA, UCB BB, VAN BB, WDP BB, CTPNV NA, SYENS BB

 PRESS RELEASE

CMB.TECH announces Q4 2024 results

CMB.TECH announces Q4 2024 results CMB.TECH ANNOUNCES Q4 2024 RESULTS STRONG RESULTS DESPITE SLOW MARKETS ANTWERP, Belgium, 27 February 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT & Euronext: CMBT) reported its non-audited financial results today for the fourth quarter ended 31 December 2024. HIGHLIGHTS Profit of USD 93.1 million in Q4 2024 bringing YTD profit to USD 870.8 million​ Delivery of 7 newbuilding vesselsSale of 4 Suezmaxes Selena (2007, 150,205 dwt), Cap Victor (2007, 158,853 dwt), Cap Felix (2008, 158,765 dwt) & Cap Lara (2007, 158,826 dwt)Sale of Win...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch